A retrospective, naturalistic study of deep brain stimulation and vagal nerve stimulation in young patients
- PMID: 38468454
- PMCID: PMC10928335
- DOI: 10.1002/brb3.3452
A retrospective, naturalistic study of deep brain stimulation and vagal nerve stimulation in young patients
Abstract
Introduction: Invasive neuromodulation interventions such as deep brain stimulation (DBS) and vagal nerve stimulation (VNS) are important treatments for movement disorders and epilepsy, but literature focused on young patients treated with DBS and VNS is limited. This retrospective study aimed to examine naturalistic outcomes of VNS and DBS treatment of epilepsy and dystonia in children, adolescents, and young adults.
Methods: We retrospectively assessed patient demographic and outcome data that were obtained from electronic health records. Two researchers used the Clinical Global Impression scale to retrospectively rate the severity of neurologic and psychiatric symptoms before and after patients underwent surgery to implant DBS electrodes or a VNS device. Descriptive and inferential statistics were used to examine clinical effects.
Results: Data from 73 patients were evaluated. Neurologic symptoms improved for patients treated with DBS and VNS (p < .001). Patients treated with DBS did not have a change in psychiatric symptoms, whereas psychiatric symptoms worsened for patients treated with VNS (p = .008). The frequency of postoperative complications did not differ between VNS and DBS groups.
Conclusion: Young patients may have distinct vulnerabilities for increased psychiatric symptoms during treatment with invasive neuromodulation. Child and adolescent psychiatrists should consider a more proactive approach and greater engagement with DBS and VNS teams that treat younger patients.
Keywords: adolescent psychology; neuropsychiatrics; neurosurgery; psychiatry.
© 2024 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Conflict of interest statement
Dr Croarkin has received research grant support from Neuronetics Inc, NeoSync Inc, and Pfizer Inc. He has received in‐kind support (equipment, supplies, and genotyping) for research studies from Assurex Health Inc., Neuronetics Inc., and MagVenture Inc. He has consulted for Engrail Therapeutics Inc., Myriad Neuroscience, Procter and Gamble, and Sunovion. Dr Vande Voort has received in‐kind support (supplies and genotyping) from Assurex Health Inc. The other authors declare that they have no conflicts of interest.
Figures


Similar articles
-
Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.Ont Health Technol Assess Ser. 2013 Oct 1;13(18):1-37. eCollection 2013. Ont Health Technol Assess Ser. 2013. PMID: 24228081 Free PMC article. Review.
-
Anterior Nucleus of the Thalamus Deep Brain Stimulation with Concomitant Vagus Nerve Stimulation for Drug-Resistant Epilepsy.Neurosurgery. 2021 Sep 15;89(4):686-694. doi: 10.1093/neuros/nyab253. Neurosurgery. 2021. PMID: 34333659
-
Therapeutic Applications of Invasive Neuromodulation in Children and Adolescents.Psychiatr Clin North Am. 2018 Sep;41(3):479-483. doi: 10.1016/j.psc.2018.04.008. Epub 2018 Jul 17. Psychiatr Clin North Am. 2018. PMID: 30098659 Free PMC article. Review.
-
The Role of Anterior Thalamic Deep Brain Stimulation as an Alternative Therapy in Patients with Previously Failed Vagus Nerve Stimulation for Refractory Epilepsy.Stereotact Funct Neurosurg. 2019;97(3):176-182. doi: 10.1159/000502344. Epub 2019 Sep 18. Stereotact Funct Neurosurg. 2019. PMID: 31533117
-
Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation vs. responsive neurostimulation or deep brain stimulation for the treatment of drug-resistant epilepsy: analyses of a large United States healthcare claims database.J Med Econ. 2022 Jan-Dec;25(1):1218-1230. doi: 10.1080/13696998.2022.2148680. J Med Econ. 2022. PMID: 36384429
References
-
- Michael, R. , Philip, G. , & William, Y. (1971). A neuropsychiatric study in childhood. London: Spastics International Medical Publications, (Pp. vi + 272; illustrated. C3.75.).
-
- Aaronson, S. T. , Sears, P. , Ruvuna, F. , Bunker, M. , Conway, C. R. , Dougherty, D. D. , Reimherr, F. W. , Schwartz, T. L. , & Zajecka, J. M. (2017). A 5‐Year observational study of patients with treatment‐resistant depression treated with vagus nerve stimulation or treatment as usual: Comparison of response, remission, and suicidality. American Journal of Psychiatry, 174(7), 640–648. 10.1176/appi.ajp.2017.16010034 - DOI - PubMed
-
- Alonso, P. , Cuadras, D. , Gabriels, L. , Denys, D. , Goodman, W. , Greenberg, B. D. , Jimenez‐Ponce, F. , Kuhn, J. , Lenartz, D. , Mallet, L. , Nuttin, B. , Real, E. , Segalas, C. , Schuurman, R. , du Montcel, S. T. , & Menchon, J. M. (2015). Deep brain stimulation for obsessive‐compulsive disorder: A meta‐analysis of treatment outcome and predictors of response. PLoS ONE, 10(7), e0133591. 10.1371/journal.pone.0133591 - DOI - PMC - PubMed
-
- Benjamini, Y. , & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289–300. 10.1111/j.2517-6161.1995.tb02031.x - DOI
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical